BRPI0820043A8 - Atividades do receptor de vitamina d e seus usos - Google Patents
Atividades do receptor de vitamina d e seus usosInfo
- Publication number
- BRPI0820043A8 BRPI0820043A8 BRPI0820043A BRPI0820043A BRPI0820043A8 BR PI0820043 A8 BRPI0820043 A8 BR PI0820043A8 BR PI0820043 A BRPI0820043 A BR PI0820043A BR PI0820043 A BRPI0820043 A BR PI0820043A BR PI0820043 A8 BRPI0820043 A8 BR PI0820043A8
- Authority
- BR
- Brazil
- Prior art keywords
- vitamin
- compounds
- receptor
- activities
- compositions
- Prior art date
Links
- 102000009310 vitamin D receptors Human genes 0.000 title abstract 3
- 108050000156 vitamin D receptors Proteins 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 3
- 239000012190 activator Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C27/00—Processes involving the simultaneous production of more than one class of oxygen-containing compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
NOVOS ATIVADORES DO RECEPTOR DE VITAMINA D E METODOS DE FABRICAÇÃO. A invenção relaciona-se a compostos que são ativadores do receptor de vitamina D, composições compreendendo tais compostos, métodos de uso de tais compostos e composições, processos para preparo de tais compostos, e intermediários obtidos durante tais processos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98916707P | 2007-11-20 | 2007-11-20 | |
US12/205,998 US8377913B2 (en) | 2007-11-20 | 2008-09-08 | Vitamin D receptor activators and methods of making |
PCT/US2008/084142 WO2009067578A2 (en) | 2007-11-20 | 2008-11-20 | New vitamin d receptor activators and methods of making |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI0820043A2 BRPI0820043A2 (pt) | 2015-05-12 |
BRPI0820043A8 true BRPI0820043A8 (pt) | 2016-03-08 |
Family
ID=40642621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0820043A BRPI0820043A8 (pt) | 2007-11-20 | 2008-11-20 | Atividades do receptor de vitamina d e seus usos |
Country Status (14)
Country | Link |
---|---|
US (1) | US8377913B2 (pt) |
EP (1) | EP2222635A2 (pt) |
JP (1) | JP5544298B2 (pt) |
KR (1) | KR101643199B1 (pt) |
CN (2) | CN101918358B (pt) |
AU (1) | AU2008326359A1 (pt) |
BR (1) | BRPI0820043A8 (pt) |
CA (1) | CA2705987A1 (pt) |
IL (1) | IL205764A (pt) |
MX (1) | MX2010005530A (pt) |
RU (1) | RU2535448C2 (pt) |
TW (1) | TWI483728B (pt) |
WO (1) | WO2009067578A2 (pt) |
ZA (1) | ZA201003324B (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102482210B (zh) * | 2009-04-17 | 2015-04-08 | 维达西姆公司 | 维生素d受体激动剂及其用途 |
JP5770261B2 (ja) * | 2010-03-23 | 2015-08-26 | ウイスコンシン アラムニ リサーチ ファンデーション | (20S)−2−メチレン−19−ノル−22−ジメチル−1α,25−ジヒドロキシビタミンD3および(20R)−2−メチレン−19−ノル−22−ジメチル−1α,25−ヒドロキシビタミンD3 |
AU2011232562B2 (en) * | 2010-03-23 | 2014-10-02 | Wisconsin Alumni Research Foundation | Diastereomers of 2-methylene-19-nor-22-methyl-1alpha,25- dihydroxyvitamin D3 |
JP6035331B2 (ja) * | 2011-06-14 | 2016-11-30 | ウイスコンシン アラムニ リサーチ ファンデーション | 3−デスオキシ−2−メチレン−19−ノル−ビタミンd類似体およびそれらの使用 |
WO2013059060A1 (en) * | 2011-10-21 | 2013-04-25 | Wisconson Alumni Research Foundation | 2-methylene-vitamin d analogs and their uses |
WO2017023617A1 (en) * | 2015-08-05 | 2017-02-09 | Wisconsin Alumni Research Foundation | Synthesis and biological activity of 2-methylene analogs of calcitriol and related compounds |
CN105732307B (zh) * | 2016-01-28 | 2019-04-19 | 科贝源(北京)生物医药科技有限公司 | 马沙骨化醇中间体的合成方法 |
EP4233989A3 (en) | 2017-06-07 | 2023-10-11 | Shifamed Holdings, LLC | Intravascular fluid movement devices, systems, and methods of use |
WO2019094963A1 (en) | 2017-11-13 | 2019-05-16 | Shifamed Holdings, Llc | Intravascular fluid movement devices, systems, and methods of use |
CN117959583A (zh) | 2018-02-01 | 2024-05-03 | 施菲姆德控股有限责任公司 | 血管内血泵以及使用和制造方法 |
JP2022540616A (ja) | 2019-07-12 | 2022-09-16 | シファメド・ホールディングス・エルエルシー | 血管内血液ポンプならびに製造および使用の方法 |
WO2021016372A1 (en) | 2019-07-22 | 2021-01-28 | Shifamed Holdings, Llc | Intravascular blood pumps with struts and methods of use and manufacture |
US11724089B2 (en) | 2019-09-25 | 2023-08-15 | Shifamed Holdings, Llc | Intravascular blood pump systems and methods of use and control thereof |
WO2021107646A1 (ko) * | 2019-11-27 | 2021-06-03 | 연성정밀화학(주) | 막사칼시톨의 제조방법 및 그를 위한 중간체 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4188345A (en) * | 1978-07-26 | 1980-02-12 | Wisconsin Alumni Research Foundation | Fluorovitamin D compounds and processes for their preparation |
JPS63208568A (ja) | 1987-02-26 | 1988-08-30 | Chugai Pharmaceut Co Ltd | 新規なビタミンd誘導体 |
JPH02162A (ja) * | 1987-06-23 | 1990-01-05 | Yamanouchi Pharmaceut Co Ltd | 新規なビタミンd↓3誘導体 |
WO1989010352A1 (en) | 1988-04-29 | 1989-11-02 | Wisconsin Alumni Research Foundation | SIDE CHAIN UNSATURATED 1alpha-HYDROXYVITAMIN D HOMOLOGS |
JPH0667898B2 (ja) | 1989-02-15 | 1994-08-31 | 大同ほくさん株式会社 | 22,23―セコビタミンd若しくはその活性型またはそれらの誘導体の製造方法 |
GB8904154D0 (en) * | 1989-02-23 | 1989-04-05 | Leo Pharm Prod Ltd | Chemical compounds |
NZ232734A (en) * | 1989-03-09 | 1991-11-26 | Wisconsin Alumni Res Found | 19-nor vitamin d derivatives and pharmaceutical compositions |
GB8914963D0 (en) * | 1989-06-29 | 1989-08-23 | Leo Pharm Prod Ltd | Chemical compounds |
GB9007236D0 (en) | 1990-03-30 | 1990-05-30 | Leo Pharm Prod Ltd | Chemical compounds |
AU650751B2 (en) * | 1991-05-28 | 1994-06-30 | Wisconsin Alumni Research Foundation | Novel synthesis of 19-nor vitamin D compounds |
GB9226860D0 (en) * | 1992-12-23 | 1993-02-17 | Leo Pharm Prod Ltd | Novel treatment |
PE28297A1 (es) * | 1995-01-26 | 1997-08-20 | Hoffmann La Roche | Empleo dermatologico de derivados de vitamina d |
US5614512A (en) | 1995-10-05 | 1997-03-25 | Wisconsin Alumni Research Foundation | 20-Oxo-pregnacalciferol analogs with binding affinity to the progesterone receptor |
KR100494205B1 (ko) * | 1996-06-04 | 2005-11-08 | 레오 파마 에이/에스 | 신규한비타민d동족체 |
GB9611603D0 (en) * | 1996-06-04 | 1996-08-07 | Leo Pharm Prod Ltd | Chemical compounds |
US20020128240A1 (en) * | 1996-12-30 | 2002-09-12 | Bone Care International, Inc. | Treatment of hyperproliferative diseases using active vitamin D analogues |
US6392071B1 (en) * | 1997-03-17 | 2002-05-21 | Wisconsin Alumni: Research Foundation | 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds |
US6207656B1 (en) | 1997-05-22 | 2001-03-27 | Cephalon, Inc. | Vitamin D analogues and their neuronal effects |
JP2001089442A (ja) * | 1999-09-20 | 2001-04-03 | Nisshin Flour Milling Co Ltd | 活性型ビタミンd誘導体 |
EP1255732A1 (en) | 2000-01-31 | 2002-11-13 | Leo Pharma A/S | Use of vitamin d-derivatives in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives |
US6894037B2 (en) | 2003-07-03 | 2005-05-17 | Wisconsin Alumni Research Foundation | 2-methylene-19-nor-20(S)-25-methyl-1α-hydroxycalciferol and its uses |
WO2006123726A1 (ja) * | 2005-05-18 | 2006-11-23 | Kyowa Hakko Kogyo Co., Ltd. | 医薬組成物 |
-
2008
- 2008-09-08 US US12/205,998 patent/US8377913B2/en not_active Expired - Fee Related
- 2008-11-20 KR KR1020107013438A patent/KR101643199B1/ko active IP Right Grant
- 2008-11-20 WO PCT/US2008/084142 patent/WO2009067578A2/en active Application Filing
- 2008-11-20 JP JP2010535053A patent/JP5544298B2/ja not_active Expired - Fee Related
- 2008-11-20 EP EP08851351A patent/EP2222635A2/en not_active Withdrawn
- 2008-11-20 CN CN200880125199.3A patent/CN101918358B/zh not_active Expired - Fee Related
- 2008-11-20 BR BRPI0820043A patent/BRPI0820043A8/pt not_active IP Right Cessation
- 2008-11-20 AU AU2008326359A patent/AU2008326359A1/en not_active Abandoned
- 2008-11-20 CA CA2705987A patent/CA2705987A1/en not_active Abandoned
- 2008-11-20 MX MX2010005530A patent/MX2010005530A/es active IP Right Grant
- 2008-11-20 RU RU2010125131/04A patent/RU2535448C2/ru not_active IP Right Cessation
- 2008-11-20 TW TW097144952A patent/TWI483728B/zh not_active IP Right Cessation
- 2008-11-20 CN CN201310597846.3A patent/CN104211626A/zh active Pending
-
2010
- 2010-05-11 ZA ZA2010/03324A patent/ZA201003324B/en unknown
- 2010-05-13 IL IL205764A patent/IL205764A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20100099181A (ko) | 2010-09-10 |
BRPI0820043A2 (pt) | 2015-05-12 |
CN104211626A (zh) | 2014-12-17 |
CA2705987A1 (en) | 2009-05-28 |
JP5544298B2 (ja) | 2014-07-09 |
RU2010125131A (ru) | 2011-12-27 |
KR101643199B1 (ko) | 2016-07-27 |
RU2535448C2 (ru) | 2014-12-10 |
US20090131379A1 (en) | 2009-05-21 |
EP2222635A2 (en) | 2010-09-01 |
ZA201003324B (en) | 2011-10-26 |
IL205764A0 (en) | 2010-11-30 |
CN101918358B (zh) | 2015-10-14 |
WO2009067578A3 (en) | 2009-11-26 |
TWI483728B (zh) | 2015-05-11 |
US8377913B2 (en) | 2013-02-19 |
MX2010005530A (es) | 2010-06-02 |
AU2008326359A1 (en) | 2009-05-28 |
CN101918358A (zh) | 2010-12-15 |
JP2011504180A (ja) | 2011-02-03 |
IL205764A (en) | 2014-12-31 |
TW200934502A (en) | 2009-08-16 |
WO2009067578A2 (en) | 2009-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0820043A8 (pt) | Atividades do receptor de vitamina d e seus usos | |
CL2012000921A1 (es) | Compuestos derivados de espiropiperidina-metilbenciloxifenil, activadores del receptor rpg-40; composicion farmaceutica que los comprende; y uso del compuesto para tratar diabetes. | |
ECSP11011390A (es) | Compuestos espiro-amidas sustituidas | |
CO6321189A2 (es) | Compuestos de tiazol y oxazol de bencen-sulfonamida | |
ECSP11011347A (es) | Nicotinamida sustituida como moduladores KCNQ2/3 | |
ECSP099619A (es) | Anticuerpos anti-robo4 y sus usos | |
PH12015500263A1 (en) | New bicyclic derivatives | |
ECSP11011439A (es) | Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750 | |
CR11492A (es) | Peptidil nitrilos y uso de los mismos como inhibidores de dipeptidil peptidasa i | |
CR20110028A (es) | Derivados de pirimidina como inhibidores de cinasa | |
NI201000005A (es) | Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico. | |
DOP2011000176A (es) | Compuestos organicos | |
DK1888541T3 (da) | Benzo(d)isoxazol-3-yl-amin-forbindelser og anvendelse af disse som vanilloidreceptorligander | |
CR20120334A (es) | Derivados de imidazopiridina como inhibidores de jak | |
CR11427A (es) | 2-fluoro-2 - desoxitetrahidrouridinas como inhibidores de citidina desaminasa | |
CL2009001686A1 (es) | Procedimiento de preparacion de agomelatina; y los compuestos intermediarios considerados. | |
ECSP11011344A (es) | Nuevos anticuerpos anti-?5?1 y sus usos | |
ECSP099616A (es) | Estabilización de vitamina b12 | |
UY29798A1 (es) | Derivados de carboxamida como antagonistas del receptor muscarínico | |
SV2009003429A (es) | Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica | |
HN2012000261A (es) | Derivados de 5-fluoro-2-oxopirimidina-1(2h)-carboxilato | |
MX2009006750A (es) | Derivados de azaadamantano espirociclicos y metodos de uso. | |
CU20080169A7 (es) | Derivados de tetrahidronaftalina, procedimientos para prepararlos. | |
ECSP11011346A (es) | 3-Amino-2-mercaptoquinolina sustituida como modulador de KCNQ2/3 | |
UY32635A (es) | Derivados de bis-(sulfonilamino) en terapia 735 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: ABBVIE INC. (US) |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |